CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash	$ 6,473	$ 8,854
Prepaid drug product for testing	611	560
Other current assets	750	179
Total current assets	7,834	9,593
Fixed assets
Furniture, fixtures & equipment	123	123
Less Accumulated Depreciation	(61)	(51)
Property, Plant and Equipment, Net	62	72
Other assets
Technology licenses	2,500	2,500
Less Accumulated Amortization	(1,450)	(1,410)
Intangible Assets, Net (Excluding Goodwill), Total	1,050	1,090
Total Assets	8,946	10,755
Current liabilities
Accounts payable	201	54
Accrued expense	699	883
Total current liabilities	900	937
Total Liabilities	900	937
Shareholders' Equity
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 3/31/16 and 12/31/15, respectively	90	90
Additional paid in capital	35,207	35,112
Accumulated deficit	(27,251)	(25,384)
Total shareholders' equity	8,046	9,818
Total Liabilities & Shareholders' Equity	$ 8,946	$ 10,755